Phenotype
|
Fish
|
Conditions
|
Figures
|
white matter disorganized, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
Fig. 5
from Jensen et al., 2006
|
extension morphology, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
Fig. 7
from Jensen et al., 2006
|
whole organism apoptotic process increased occurrence, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
Fig. 4
from Carayannopoulos et al., 2014
Fig. 6,
Fig. S6
from Jensen et al., 2006
|
midbrain hindbrain boundary absent, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
Fig. 3
from Jensen et al., 2006
|
head opaque, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
Fig. 1
from Jensen et al., 2010
Fig. 3,
Fig. 7
from Jensen et al., 2006
|
glucose import decreased rate, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
Fig. 4
from Jensen et al., 2010
Fig. 6,
Fig. 7
from Jensen et al., 2006
|
central nervous system apoptotic process increased occurrence, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
Fig. 4
from Carayannopoulos et al., 2014
Fig. 6
from Jensen et al., 2006
|
medial longitudinal fasciculus axonal fasciculation decreased process quality, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
Fig. 5
from Jensen et al., 2006
|
brain compartment boundary amorphous, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
Fig. 3,
Fig. 7
from Jensen et al., 2006
|
fourth ventricle increased size, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
Fig. 3,
Fig. 7
from Jensen et al., 2006
|
extension decreased thickness, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
Fig. 3
from Jensen et al., 2006
|
whole organism dead, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
text only
from Jensen et al., 2006
|
extension decreased size, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
Fig. 3
from Jensen et al., 2006
|
trigeminal ganglion neuron decreased amount, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
Fig. 5
from Jensen et al., 2006
|
lateral longitudinal fasciculus axonal fasciculation decreased process quality, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
Fig. 5
from Jensen et al., 2006
|
median fin fold morphology, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
Fig. 3
from Jensen et al., 2006
|
midbrain hindbrain boundary decreased size, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
Fig. 5
from Jensen et al., 2006
|
central nervous system morphology, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
Fig. 3,
Fig. 7
from Jensen et al., 2006
|
tectal ventricle increased size, abnormal
|
WT + MO1-slc2a1a
|
standard conditions
|
Fig. 3
from Jensen et al., 2006
|
macrophage phagocytosis decreased occurrence, abnormal
|
gl22Tg + MO1-slc2a1a
|
control
|
Fig. 3
from Morioka et al., 2018
|
central nervous system morphology, ameliorated
|
WT + MO1-badb + MO1-slc2a1a
|
standard conditions
|
Fig. 7
from Jensen et al., 2006
|
brain compartment boundary morphology, ameliorated
|
WT + MO1-badb + MO1-slc2a1a
|
standard conditions
|
Fig. 7
from Jensen et al., 2006
|
extension morphology, ameliorated
|
WT + MO1-badb + MO1-slc2a1a
|
standard conditions
|
Fig. 7
from Jensen et al., 2006
|
fourth ventricle size, ameliorated
|
WT + MO1-badb + MO1-slc2a1a
|
standard conditions
|
Fig. 7
from Jensen et al., 2006
|
glucose import decreased rate, abnormal
|
WT + MO1-badb + MO1-slc2a1a
|
standard conditions
|
Fig. 7
from Jensen et al., 2006
|
whole organism apoptotic process occurrence, ameliorated
|
WT + MO1-badb + MO1-slc2a1a
|
standard conditions
|
Fig. S6
from Jensen et al., 2006
|
central nervous system morphology, ameliorated
|
WT + MO1-slc2a1a + MO2-badb
|
standard conditions
|
Fig. 7
from Jensen et al., 2006
|
brain compartment boundary morphology, ameliorated
|
WT + MO1-slc2a1a + MO2-badb
|
standard conditions
|
Fig. 7
from Jensen et al., 2006
|
extension morphology, ameliorated
|
WT + MO1-slc2a1a + MO2-badb
|
standard conditions
|
Fig. 7
from Jensen et al., 2006
|
fourth ventricle size, ameliorated
|
WT + MO1-slc2a1a + MO2-badb
|
standard conditions
|
Fig. 7
from Jensen et al., 2006
|
glucose import decreased rate, abnormal
|
WT + MO1-slc2a1a + MO2-badb
|
standard conditions
|
Fig. 7
from Jensen et al., 2006
|
whole organism apoptotic process occurrence, ameliorated
|
WT + MO1-slc2a1a + MO2-badb
|
standard conditions
|
Fig. S6
from Jensen et al., 2006
|